H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 41 Citations 8,146 366 World Ranking 15886 National Ranking 5

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His main research concerns Cancer, Cancer research, microRNA, Immune system and Metastasis. His Cancer study combines topics from a wide range of disciplines, such as Epigenetics and Drug resistance. His Cancer research research is multidisciplinary, incorporating elements of Regulator, Apoptosis, Breast cancer and Molecular biology.

His research integrates issues of Gene expression, Oncology, Bioinformatics, Disease and Cell cycle in his study of microRNA. His biological study spans a wide range of topics, including Receptor and Blockade. The Metastasis study combines topics in areas such as Wnt signaling pathway, Cancer stem cell, Tumor progression and Clone, Monoclonal antibody.

His most cited work include:

  • The Different Mechanisms of Cancer Drug Resistance: A Brief Review. (318 citations)
  • Molecular Mechanisms of Apoptosis and Roles in Cancer Development and Treatment (206 citations)
  • Herbal medicine as inducers of apoptosis in cancer treatment. (160 citations)

What are the main themes of his work throughout his whole career to date?

Behzad Baradaran mostly deals with Cancer research, Cancer, Apoptosis, microRNA and Cancer cell. His Cancer research research is multidisciplinary, relying on both MTT assay, Cell growth, Immune system, Transfection and Metastasis. His Cancer study combines topics in areas such as Gene and Bioinformatics.

His Apoptosis study integrates concerns from other disciplines, such as Cytotoxic T cell, Cell culture, Molecular biology and Cytotoxicity. The concepts of his Molecular biology study are interwoven with issues in Antibody and Monoclonal antibody. His work deals with themes such as Cell migration, Carcinogenesis, Downregulation and upregulation, Signal transduction and Breast cancer, which intersect with microRNA.

He most often published in these fields:

  • Cancer research (41.82%)
  • Cancer (24.10%)
  • Apoptosis (19.79%)

What were the highlights of his more recent work (between 2019-2021)?

  • Cancer research (41.82%)
  • Cancer (24.10%)
  • microRNA (18.59%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Cancer research, Cancer, microRNA, Cancer cell and Immune system. His research integrates issues of Cell growth, Apoptosis, Cell cycle, Transfection and Metastasis in his study of Cancer research. The various areas that Behzad Baradaran examines in his Apoptosis study include Cell culture, Cytotoxic T cell, Flow cytometry and Cytotoxicity.

His Cancer research incorporates elements of Gene, Combination therapy and Drug resistance. His research in microRNA intersects with topics in PI3K/AKT/mTOR pathway, Protein kinase B, Signal transduction, Cell migration and Carcinogenesis. Behzad Baradaran interconnects CD44 and Small interfering RNA in the investigation of issues within Cancer cell.

Between 2019 and 2021, his most popular works were:

  • Lateral flow assays towards point-of-care cancer detection: A review of current progress and future trends (34 citations)
  • Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis. (24 citations)
  • Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. (24 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

The scientist’s investigation covers issues in Cancer research, Cancer, microRNA, Cancer cell and Immune system. His Cancer research research is multidisciplinary, incorporating perspectives in Cell migration, Cell growth, Cancer stem cell, Apoptosis and Metastasis. His Cancer research incorporates themes from Regulator, Gene expression, Drug resistance and Bioinformatics.

Behzad Baradaran combines subjects such as Cell culture, Protein kinase B, Signal transduction, Suppressor and Downregulation and upregulation with his study of microRNA. Behzad Baradaran has researched Cancer cell in several fields, including Angiogenesis, CD44, Small interfering RNA, Immunogenicity and Boronic acid. His Immune system research integrates issues from Tumor progression, Transcription factor and Antigen.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Different Mechanisms of Cancer Drug Resistance: A Brief Review.

Behzad Mansoori;Ali Mohammadi;Sadaf Davudian;Solmaz Shirjang.
Advanced Pharmaceutical Bulletin (2017)

580 Citations

Molecular Mechanisms of Apoptosis and Roles in Cancer Development and Treatment

Samira Goldar;Mahmoud Shekari Khaniani;Sima Mansoori Derakhshan;Behzad Baradaran.
Asian Pacific Journal of Cancer Prevention (2015)

410 Citations

Herbal medicine as inducers of apoptosis in cancer treatment.

Safarzadeh E;Sandoghchian Shotorbani S;Baradaran B.
Advanced Pharmaceutical Bulletin (2014)

359 Citations

Treating cancer with microRNA replacement therapy: A literature review.

Nayer Hosseinahli;Mahyar Aghapour;Pascal H. G. Duijf;Behzad Baradaran.
Journal of Cellular Physiology (2018)

221 Citations

RNA interference and its role in cancer therapy.

Mansoori B;Sandoghchian Shotorbani S;Baradaran B.
Advanced Pharmaceutical Bulletin (2014)

189 Citations

PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy.

Fereydoon Abedi-Gaballu;Fereydoon Abedi-Gaballu;Gholamreza Dehghan;Maryam Ghaffari;Maryam Ghaffari;Reza Yekta.
Applied Materials Today (2018)

153 Citations

Phage display as a promising approach for vaccine development.

Leili Aghebati-Maleki;Babak Bakhshinejad;Behzad Baradaran;Morteza Motallebnezhad.
Journal of Biomedical Science (2016)

142 Citations

The role of microRNAs in colorectal cancer.

Ali Mohammadi;Behzad Mansoori;Behzad Baradaran.
Biomedicine & Pharmacotherapy (2016)

137 Citations

The relation between PI3K/AKT signalling pathway and cancer.

Saeed Noorolyai;Neda Shajari;Elham Baghbani;Sanam Sadreddini.
Gene (2019)

133 Citations

The paradox of Th17 cell functions in tumor immunity.

Zahra Asadzadeh;Hamed Mohammadi;Elham Safarzadeh;Maryam Hemmatzadeh.
Cellular Immunology (2017)

126 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Behzad Baradaran

Mohammad Hasanzadeh

Mohammad Hasanzadeh

Tabriz University of Medical Sciences

Publications: 26

Amir Razmjou

Amir Razmjou

University of Technology Sydney

Publications: 22

Michael R. Hamblin

Michael R. Hamblin

University of Johannesburg

Publications: 22

Alireza Khataee

Alireza Khataee

Gebze Technical University

Publications: 21

Ali Maleki

Ali Maleki

Iran University of Science and Technology

Publications: 19

Karl Deisseroth

Karl Deisseroth

Stanford University

Publications: 14

Nima Rezaei

Nima Rezaei

Tehran University of Medical Sciences

Publications: 13

Amirhossein Sahebkar

Amirhossein Sahebkar

Mashhad University of Medical Sciences

Publications: 12

Gautam Sethi

Gautam Sethi

National University of Singapore

Publications: 11

Miguel de la Guardia

Miguel de la Guardia

University of Valencia

Publications: 10

Xiangyang Shi

Xiangyang Shi

Donghua University

Publications: 8

Thomas Efferth

Thomas Efferth

Johannes Gutenberg University of Mainz

Publications: 8

Zhe-Sheng Chen

Zhe-Sheng Chen

St. John's University

Publications: 7

Francisco Veiga

Francisco Veiga

University of Coimbra

Publications: 7

Abolfazl Akbarzadeh

Abolfazl Akbarzadeh

Tabriz University of Medical Sciences

Publications: 7

Seyed Hossein Hoseinifar

Seyed Hossein Hoseinifar

Gorgan University of Agricultural Sciences and Natural Resources

Publications: 7

Something went wrong. Please try again later.